With Nasal Ease U.S. Launch, Hi-Tech Bids For Allergy Relief Market Share
This article was originally published in The Tan Sheet
Executive Summary
Hi-Tech Pharmacal plans to launch its homeopathic allergy reliever Nasal Ease in the U.S. in a bid to capture some of the market share Matrixx Initiatives lost when it withdrew its intranasal Zicam products.
You may also be interested in...
In Brief
Perrigo debuts Rogaine Foam equivalent; Pfizer patent suit applies heat to J&J/McNeil; Merck KGaA consumer unit beats forecast; Abbott seeks expanded vitamin D3 use; Hi-Tech Pharmacal adds to homeopathics portfolio; more news In Brief.
In Brief
FDA extends NDI comment deadline
In Brief
FDA extends NDI comment deadline